Add BrightSurf on Google Email

New molecular map reveals how cells control traffic between the nucleus and cytoplasm

A team of scientists has created a detailed model of how cells regulate traffic through the nuclear pore complex, revealing that flexible protein chains create an entropic barrier that admits only properly escorted cargo. This breakthrough sheds light on diseases like cancer, Alzheimer's, and ALS, where this transport system fails.

SourceThe Hebrew University of Jerusalem·JournalProceedings of the National Academy of Sciences·TypeComputational simulation/modeling·DateOct 19, 2025

New trial finds diabetes drug and nasal insulin improve brain health in  early Alzheimer’s disease

A new trial finds that empagliflozin and intranasal insulin safely improve brain health in people with mild cognitive impairment and early Alzheimer's disease. The medications target metabolic and vascular problems, improving memory, brain health, and blood flow.

SourceAtrium Health Wake Forest Baptist·JournalAlzheimer’s & Dementia·TypeRandomized controlled/clinical trial·DateOct 16, 2025

Why women's brains face higher risk: scientists pinpoint X-chromosome gene behind MS and Alzheimer's

Researchers at UCLA Health have identified a sex-chromosome linked gene that drives inflammation in the female brain, making women more susceptible to conditions like Alzheimer's disease and multiple sclerosis. Deactivating this gene and using diabetes medication metformin showed promising results in reducing symptoms in female mice.

SourceUniversity of California - Los Angeles Health Sciences·JournalScience Translational Medicine·DateOct 15, 2025

Research gives insight into effect of neurodegenerative diseases on speech rhythm

Researchers at the University of Kansas found that individuals with ALS can improve their speech rhythm control by speaking more slowly, making it easier for others to understand. The study aims to develop personalized speech therapy strategies for patients with progressive communicative disorders.

SourceUniversity of Kansas·JournalJournal of Speech Language and Hearing Research·TypeData/statistical analysis·DateOct 10, 2025

In a nasal spray, gold “nanoparticles” deliver a targeted treatment to the brain. A potentially revolutionary approach to mental disorders and neurodegenerative diseases already has a patent

Researchers develop a new nanotechnological device that delivers lithium directly to the brain, targeting glycogen synthase kinase-3 beta enzyme. The treatment achieves similar effects as oral lithium but with lower concentrations and reduced side effects.

SourceUniversita Cattolica del Sacro Cuore·JournalAdvanced Materials·TypeExperimental study·DateOct 8, 2025

Barrow study: Ambient TCE exposure suggests link to Parkinson’s disease risk nationwide

A Barrow Neurological Institute study found a positive association between ambient trichloroethylene (TCE) and Parkinson's disease risk. The researchers identified a potential link between TCE exposure and an increased risk of Parkinson's disease, particularly in individuals living near facilities emitting the chemical.

SourceDignity Health Arizona·JournalNeurology·TypeObservational study·DateOct 1, 2025

ALS appears to be an autoimmune disease

Researchers at La Jolla Institute for Immunology discovered that ALS is likely caused by an autoimmune reaction triggered by inflammatory CD4+ T cells targeting specific proteins in the nervous system. Anti-inflammatory CD4+ T cells may slow disease progression and prolong survival times.

SourceLa Jolla Institute for Immunology·JournalNature·TypeExperimental study·DateOct 1, 2025

New protein interaction map sheds light on how brain cell communication breaks down in Alzheimer’s disease

A new study provides a comprehensive view of how brain cells interact in Alzheimer's disease, mapping protein networks that reveal communication failures and point to new therapeutic opportunities. The researchers discovered that disruptions in glia-neuron communication are closely linked to the progression of Alzheimer's disease.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalCell·TypeComputational simulation/modeling·DateSep 25, 2025

Tiny treatment system helps fight back against neuroinflammation in the brain

A new study published in Biomaterials has developed a tiny, bioengineered system to deliver anti-inflammatory proteins to specific targets in the brain. The AstroCapsules, which are 300 micrometers in diameter, were confirmed to function when implanted into the brain and reduced neuroinflammation by measuring inflammatory biomarkers.

SourceHouston Methodist·JournalBiomaterials·TypeExperimental study·DateSep 25, 2025

In pregnant mice with severe flu, harmful molecules can breach fetal barriers

A new study from the University of Illinois shows that severe flu infection in pregnant mice leads to a breakdown in placental and brain barriers, allowing potentially harmful molecules to accumulate in the fetal brain. Fibrinogen accumulation has also been linked to neuroinflammatory conditions, and researchers found it accumulated in...

Mount Sinai receives $8 million from DataPhilanthropy to accelerate drug discovery for CADASIL and related brain disorders

The Mount Sinai Health System has received an $8 million grant from DataPhilanthropy to fuel urgently needed research into CADASIL, a genetic disease associated with migraines, strokes, cognitive decline, and dementia. The center will focus on extending brain healthspan and preventing dementia in individuals with genetic risk for cereb...

Chinese Medical Journal study reviews the association between lipid metabolism and Parkinson’s disease

A Chinese Medical Journal study reviews the association between lipid metabolism and Parkinson’s disease. The research highlights how lipid disruptions contribute to α-Syn aggregation, mitochondrial dysfunction, and neuroinflammation, suggesting lipids as a promising therapeutic target for PD.

SourceChinese Medical Journals Publishing House Co., Ltd.·JournalChinese Medical Journal·TypeSystematic review·DateSep 17, 2025

Vitamin K analogues may help transform the treatment of neurodegenerative diseases

Researchers synthesized hybrid vitamin K analogues with enhanced neuroactive properties, exhibiting threefold greater potency in inducing neural progenitor cell differentiation compared to natural vitamin K. The compounds preserved vitamin K and retinoic acid's biological activity via the SXR and RAR receptors.

SourceShibaura Institute of Technology·JournalACS Chemical Neuroscience·TypeExperimental study·DateSep 12, 2025

Alzheimer’s disease digital resources lacking for Latinos, Hispanics in Los Angeles years after COVID-19, study finds

A UCLA Health study found that only a handful of top Alzheimer's disease organizations in Los Angeles County had features or tools to improve access for Latino and Hispanic families. The study highlights the need for accessible digital solutions to close the existing digital divide among these communities.

SourceUniversity of California - Los Angeles Health Sciences·JournalJournal of Medical Internet Research·DateSep 10, 2025

Training to improve memory

Researchers at ETH Zurich found that exergame training improved cognitive performance, memory, and structural brain changes in individuals with mild cognitive impairment. The study suggests a potential causal effect of the training on disease-modifying effects and plans for longer-term studies are underway.

SourceETH Zurich·JournalAlzheimer s Research & Therapy·DateSep 8, 2025

Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations

Researchers found that individuals from African American, Hispanic and Asian groups were less likely to have elevated amyloid in the brain based on blood levels of p-tau217. This finding suggests that these groups may have a lower prevalence of amyloid and are not at sufficient risk to qualify for amyloid-lowering trials.

SourceKeck School of Medicine of USC·TypeObservational study·DateSep 5, 2025

Alzheimer’s erodes brain cells’ control of gene expression, undermining function, cognition

A new study reveals that Alzheimer's progression is characterized by a breakdown of epigenomic stability, leading to compromised compartmentalization and the loss of gene regulation. The research provides insights into the molecular mechanisms driving disease progression and resilience, shedding light on potential new treatments.

SourcePicower Institute at MIT·JournalCell·TypeExperimental study·DateSep 2, 2025

Why repetitive DNA has an active role in the human brain

Researchers at Lund University found that specific sequences within non-coding genome help shape the developing human brain. Disrupting these sequences leads to abnormalities in gene activity and brain organoid growth, highlighting their importance in regulating genes and development.

SourceLund University·JournalCell Genomics·TypeExperimental study·DateAug 25, 2025

Brain’s blood flow could change how we understand and treat Alzheimer’s

A new study from the University of Southern California has found that measuring brain blood flow dynamics may be key to understanding and treating Alzheimer's disease. The research team developed a novel 'physio-marker' called the Cerebrovascular Dynamics Index (CDI) using non-invasive Doppler ultrasound and near-infrared spectroscopy.

SourceUniversity of Southern California·JournalAlzheimer s & Dementia Diagnosis Assessment & Disease Monitoring·TypeExperimental study·DateAug 25, 2025

Researcher from FAPESP-supported center participates in international initiative to improve oxylipin analysis

An international team of researchers established standardized guidelines for analyzing oxylipins, bioactive lipids related to inflammation and disease. The guidelines aim to improve reproducibility in laboratories and facilitate the transfer of scientific discoveries to clinical practice.

Neural navigation: FAU engineers, sensing institute map brain’s blood flow

Researchers from FAU and the Sensing Institute created a detailed computer model of the mouse brain's vasculature, simulating how brain blood vessels respond to hemodynamics and vasodynamics. The model shows that transitional vessels play a critical role in regulating flow and protecting the brain during increased activity.

SourceFlorida Atlantic University·JournalPLOS One·TypeComputational simulation/modeling·DateAug 12, 2025

Davos Alzheimer’s collaborative launches five-year plan to strengthen brain health in Africa and beyond

The Davos Alzheimer's Collaborative has launched a five-year plan to strengthen brain health in Africa and beyond, focusing on prevention and economic resilience. The six priorities of the 6x5 Plan include building resilient systems that support lifelong brain health and addressing cardiometabolic and lifestyle factors.

SourceDavos Alzheimer's Collaborative·JournalNature Medicine·TypeCommentary/editorial·DateAug 7, 2025

The first 25 years of SuperAger research

SuperAgers, individuals with exceptional memory performance beyond their age, have been studied for 25 years. Their brains show a distinct neurobiological profile, linked to resistance and resilience mechanisms that may prevent Alzheimer's disease progression.

SourceNorthwestern University·JournalAlzheimer s & Dementia·DateAug 7, 2025